{"transactions":[{"id":730362,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:05:08.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting."}],"balance_after":34000,"derivative":{"exercise_price":1.79,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001835597-26-000029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000183559726000029/form4.xml","form_type":"4"}},{"id":863923,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-03-04T21:37:24.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Board of Directors on January 26, 2026, with a grant date of March 2, 2026, and represents the Reporting Person's annual equity award for 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests in full on March 2, 2027, subject to the Reporting Person's continued service on the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":5.35,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001283301-26-000008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000128330126000008/ownership.xml","form_type":"4"}},{"id":940461,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:05:23.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":30456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 30,456 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,456 unvested restricted stock units."}],"balance_after":85725,"source":{"system":"sec-edgar","filing":"0001283301-26-000003","document":"wk-form4_1768338320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000128330126000003/wk-form4_1768338320.xml","form_type":"4"}},{"id":1119410,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T10:54:26.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting."}],"balance_after":16000,"derivative":{"exercise_price":1.51,"exercise_date":"2026-06-04","expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001127602-25-016931","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000112760225016931/form4.xml","form_type":"4"}},{"id":1224988,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-03-05T21:25:12.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Board of Directors on February 12, 2025, with a grant date of March 3, 2025, and represents the Reporting Person's annual equity award for 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests in full on March 3, 2026, subject to the Reporting Person's continued service on the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":2.46,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-25-033649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025033649/ownership.xml","form_type":"4"}},{"id":1304645,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-13T21:04:54.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":15789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 15,789 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,789 unvested restricted stock units."}],"balance_after":55269,"source":{"system":"sec-edgar","filing":"0001283301-25-000002","document":"wk-form4_1736802287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000128330125000002/wk-form4_1736802287.xml","form_type":"4"}},{"id":1341110,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-06T21:05:03.000Z","date":"2024-12-04","kind":"purchase","planned":false,"acquired":true,"shares":25975,"price":3.85,"value":100003.75,"ownership":{"direct":false,"nature":"By Revocable Trust"},"balance_after":25975,"source":{"system":"sec-edgar","filing":"0000950170-24-134067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024134067/ownership.xml","form_type":"4"}},{"id":1471497,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-24T20:11:03.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall fully vest on the first anniversary after the Grant Date (06/20/2024), subject to a continued service relationship."}],"balance_after":23000,"derivative":{"exercise_price":10.65,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000950170-24-076719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024076719/ownership.xml","form_type":"4"}},{"id":1471908,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T20:11:55.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting."}],"balance_after":13000,"derivative":{"exercise_price":16.8,"exercise_date":"2025-06-20","expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001127602-24-019124","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000112760224019124/form4.xml","form_type":"4"}},{"id":1681154,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-11T21:06:57.000Z","date":"2024-01-09","kind":"grant","planned":false,"acquired":true,"shares":19480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 19,480 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,480 unvested restricted stock units."}],"balance_after":39480,"source":{"system":"sec-edgar","filing":"0001283301-24-000002","document":"wk-form4_1705007207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000128330124000002/wk-form4_1705007207.xml","form_type":"4"}},{"id":1711783,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-12-14T23:30:25.000Z","date":"2023-12-12","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vests 12/12/2024."}],"balance_after":930000,"derivative":{"exercise_price":0.24,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001437749-23-034470","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034470/rdgdoc.xml","form_type":"4"}},{"id":1791853,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-31T18:41:53.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":2.98,"expiration_date":"2032-09-13","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-23-047821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000120919123047821/doc4.xml","form_type":"4"}},{"id":1791852,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-31T18:41:53.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":160000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":11.32,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001209191-23-047821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000120919123047821/doc4.xml","form_type":"4"}},{"id":1791851,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-31T18:41:53.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":241593,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each unvested Company Stock Option. Pursuant to the Merger Agreement, each Company Stock Option that was not in the money as of the Effective Time was cancelled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":3.88,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":241593},"source":{"system":"sec-edgar","filing":"0001209191-23-047821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000120919123047821/doc4.xml","form_type":"4"}},{"id":1791850,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-31T18:41:53.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":156250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each option to purchase shares granted under an Issuer equity plan (each, a Company Stock Option) that was outstanding and unvested as of that date. As of the Effective Time, each in-the-money Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled in-the-money Company Stock Option was entitled to receive, in consideration of the cancellation of such Company Stock Option, (i) an amount in cash (less applicable tax withholdings and without interest) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess of $2.13 over the applicable exercise price per share under such Company Stock Option and (ii) one contingent value right for each share subject thereto."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each option to purchase shares granted under an Issuer equity plan (each, a Company Stock Option) that was outstanding and unvested as of that date. As of the Effective Time, each in-the-money Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled in-the-money Company Stock Option was entitled to receive, in consideration of the cancellation of such Company Stock Option, (i) an amount in cash (less applicable tax withholdings and without interest) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess of $2.13 over the applicable exercise price per share under such Company Stock Option and (ii) one contingent value right for each share subject thereto."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 16, 2023, the Issuer's Board of Directors vested in full each option to purchase shares granted under an Issuer equity plan (each, a Company Stock Option) that was outstanding and unvested as of that date. As of the Effective Time, each in-the-money Company Stock Option that was outstanding immediately prior to the Effective Time was cancelled, and, in exchange therefor, the holder of such cancelled in-the-money Company Stock Option was entitled to receive, in consideration of the cancellation of such Company Stock Option, (i) an amount in cash (less applicable tax withholdings and without interest) equal to the product of (x) the total number of shares subject to such Company Stock Option immediately prior to the Effective Time multiplied by (y) the excess of $2.13 over the applicable exercise price per share under such Company Stock Option and (ii) one contingent value right for each share subject thereto."}],"balance_after":0,"derivative":{"exercise_price":2.08,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":156250},"source":{"system":"sec-edgar","filing":"0001209191-23-047821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000120919123047821/doc4.xml","form_type":"4"}},{"id":1791849,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-31T18:41:53.000Z","date":"2023-08-31","kind":"other","planned":false,"acquired":false,"shares":316753,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger entered into by and among the Issuer, MediPacific, Inc. (Parent) and MediPacific Sub, Inc., a wholly-owned subsidiary of Parent (Purchaser), dated as of July 16, 2023 (Merger Agreement), pursuant to which the Purchaser completed a tender offer for the shares of common stock of the Issuer and thereafter merged with and into the Issuer effective as of August 31, 2023 (Effective Time)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement and Purchaser's offer to purchase, the shares of common stock were tendered to Purchaser in consideration for a per share price of (i) $2.13 in cash, net of applicable taxes and without interest, and (ii) one non-transferable contractual contingent value right."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-047821","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000120919123047821/doc4.xml","form_type":"4"}},{"id":1844110,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T20:11:19.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting."}],"balance_after":12000,"derivative":{"exercise_price":9.61,"exercise_date":"2024-06-22","expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001127602-23-019406","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000112760223019406/form4.xml","form_type":"4"}},{"id":1865804,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-06-06T20:34:41.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% vests 6/2/2024."}],"balance_after":700000,"derivative":{"exercise_price":0.55,"expiration_date":"2033-06-02","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001437749-23-016757","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923016757/rdgdoc.xml","form_type":"4"}},{"id":1865803,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-06-06T20:34:41.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":470000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vest monthly over three years."}],"balance_after":470000,"derivative":{"exercise_price":0.55,"expiration_date":"2033-06-02","underlying":"Common Stock","underlying_shares":470000},"source":{"system":"sec-edgar","filing":"0001437749-23-016757","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923016757/rdgdoc.xml","form_type":"4"}},{"id":2032628,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T21:29:28.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":156250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the 1st day of each month after the Grant Date (02/01/2023), subject to continued service relationship."}],"balance_after":156250,"derivative":{"exercise_price":2.08,"expiration_date":"2033-02-01","underlying":"Common Stock","underlying_shares":156250},"source":{"system":"sec-edgar","filing":"0001209191-23-006867","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000120919123006867/doc4.xml","form_type":"4"}},{"id":2057069,"issuer":{"id":7814,"kind":"organization","name":"LISATA THERAPEUTICS, INC.","symbol":"LSTA"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-11T21:17:24.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 20,000 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,000 unvested restricted stock units."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001283301-23-000002","document":"wf-form4_167347182299908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/320017/000128330123000002/wf-form4_167347182299908.xml","form_type":"4"}},{"id":2157213,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-16T20:12:22.000Z","date":"2022-09-14","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over two years with 1/2 of the shares subject to such option vesting and becoming exercisable on September 14, 2023, and the remaining 1/2 of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the 14th day of each month thereafter, subject to continued service relationship."}],"balance_after":125000,"derivative":{"exercise_price":2.98,"expiration_date":"2032-09-14","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-050309","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000120919122050309/doc4.xml","form_type":"4"}},{"id":2276003,"issuer":{"id":6253,"kind":"organization","name":"PepGen Inc."},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-10T22:49:25.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date."}],"balance_after":11667,"derivative":{"exercise_price":12,"expiration_date":"2032-05-05","underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0000899243-22-017495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000089924322017495/doc4.xml","form_type":"4"}},{"id":2416197,"issuer":{"id":110063,"kind":"organization","name":"PARDES BIOSCIENCES, INC.","symbol":"PRDS"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T00:07:29.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in substantially equal monthly installments over four years from February 1, 2022, subject to a continued service relationship. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2021 Stock Option and Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":160000,"derivative":{"exercise_price":11.32,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0000899243-22-004219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283301/000089924322004219/doc4.xml","form_type":"4"}},{"id":4088082,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase common stock","published_at":"2018-01-26T21:27:30.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":81000,"derivative":{"exercise_price":20,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001209191-18-005601","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919118005601/doc4.xml","form_type":"4"}},{"id":4468565,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-03T21:06:43.000Z","date":"2016-12-13","kind":"gift","acquired":false,"shares":2596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a bona fide gift transaction exempt under Section 16(b). This transaction did not involve the sale of securities."}],"balance_after":245000,"source":{"system":"sec-edgar","filing":"0001209191-17-007566","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919117007566/doc5.xml","form_type":"5"}},{"id":4468564,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-03T21:06:43.000Z","date":"2015-11-11","kind":"gift","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is a bona fide gift transaction exempt under Section 16(b). This transaction did not involve the sale of securities."}],"balance_after":247596,"source":{"system":"sec-edgar","filing":"0001209191-17-007566","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919117007566/doc5.xml","form_type":"5"}},{"id":4481855,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":36298,"kind":"person","name":"HENSON HEIDI","position":1,"cik":"0001283301","reported_name":"HENSON HEIDI","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase common stock","published_at":"2017-01-25T22:28:58.000Z","date":"2017-01-23","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":100000,"derivative":{"exercise_price":6.15,"expiration_date":"2027-01-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-17-005561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919117005561/doc4.xml","form_type":"4"}}]}